What makes an effective eye drop?

One that dissolves cystine crystals throughout the cornea, not just the top layers
One that showed a 40% decrease in cystine crystals in the cornea after 90 days
One that has convenient 4 times a day dosing

That one is

LEARN MORE

CystadropsCare offers ongoing support tailored to meet the needs of people using CYSTADROPS and their caregivers.

LEARN MORE

The Patient Advocacy Liaison Program

Providing one-on-one personalized support for patients taking CYSTADROPS, their caregivers, and families.

LEARN MORE ENROLL NOW

Information provided by the PAL program is for educational purposes only and is not intended to replace the advice of patients’ healthcare providers.

Cystadrops Patient Advocacy Liaison Helga Nemaric

HELGA,
PATIENT ADVOCACY LIAISON

Considering CYSTADROPS?

LEARN MORE

Starting CYSTADROPS?

WATCH THE VIDEO

Currently taking CYSTADROPS?

GET SUPPORT

Indications and Usage

CYSTADROPS (cysteamine ophthalmic solution) 0.37% is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis.

Important Safety Information

To minimize the risk of contamination, do not touch the dropper tip to any surface. Keep bottle tightly closed when not in use.
A condition where the pressure inside the skull increases for unknown reasons has been reported with cysteamine taken by mouth or cysteamine eye drops (used at the same time as cysteamine taken by mouth). This condition went away with the addition of medicine that increases the production of urine.
Contains the preservative benzalkonium chloride. Contact with soft contact lenses should be avoided. Remove contact lenses prior to application. Lenses may be reinserted 15 minutes following administration.
The most common side effects are eye pain (stinging), blurred vision, eye irritation (burning), eye redness, discomfort at instillation site (sticky eyes or sticky eyelids), eye itching, watery eyes, medicine deposit on the eye lashes or around the eyes.
To report SUSPECTED SIDE EFFECTS, contact Recordati Rare Diseases Inc. at 1-888-575-8344, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

INDICATIONS AND IMPORTANT SAFETY INFORMATION

+ SEE MORE

Important Safety Information

To minimize the risk of contamination, do not touch the dropper tip to any surface. Keep bottle tightly closed when not in use.